G protein‐coupled receptor modulation of striatal dopamine transmission: Implications for psychoactive drug effects
Mydirah Littlepage‐Saunders, Michael J. Hochstein, Doris S. Chang, Kari A. Johnson
British Journal of Pharmacology June 1, 2023 DOI: 10.1111/bph.16151 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Citations | 5 |
| Key findings | The authors propose that GPCRs regulating striatal dopamine transmission act through two distinct routes: modulation of somatic action potential firing of dopamine neurons, and regulation of local acetylcholine-dependent dopamine release from striatal cholinergic interneurons. They argue these two modes likely affect different aspects of behaviour and psychoactive drug actions, and highlight the relevance of these mechanisms to drug effects on physiology and behaviour. |
Abstract
Dopamine transmission in the striatum is a critical mediator of the rewarding and reinforcing effects of commonly misused psychoactive drugs. G protein-coupled receptors (GPCRs) that bind a variety of neuromodulators including dopamine, endocannabinoids, acetylcholine and endogenous opioid peptides regulate dopamine release by acting on several components of dopaminergic circuitry. Striatal dopamine release can be driven by both somatic action potential firing and local mechanisms that depend on acetylcholine released from striatal cholinergic interneurons. GPCRs that primarily regulate somatic firing of dopamine neurons via direct effects or modulation of synaptic inputs are likely to affect distinct aspects of behaviour and psychoactive drug actions compared with those GPCRs that primarily regulate local acetylcholine-dependent dopamine release in striatal regions. This review will highlight mechanisms by which GPCRs modulate dopaminergic transmission and the relevance of these findings to psychoactive drug effects on physiology and behaviour.
Citations in the library
Cites 2
- Cannabinoid CB1 Receptors Are Expressed in a Subset of Dopamine Neurons and Underlie Cannabinoid-Induced Aversion, Hypoactivity, and Anxiolytic Effects in Mice. Journal of Neuroscience January 18, 2023
- Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism. Neuropharmacology November 1, 2014